Dominic Nicholas Jackson
Director/Board Member at Redx Oncology Ltd.
Profile
Dominic Nicholas Jackson is currently a Director at Redx Oncology Ltd.
and a Member at The Chartered Institute For Securities & Investment.
Previously, he worked as the Chief Financial Officer & Executive Director at Redx Pharma Plc from 2017 to 2019.
He also worked as a Member at the Institute for Turnaround.
Dominic Nicholas Jackson active positions
Companies | Position | Start |
---|---|---|
The Chartered Institute For Securities & Investment
The Chartered Institute For Securities & Investment General GovernmentGovernment The Chartered Institute For Securities & Investment operates as securities and investment educational institute. It is the professional body for those who work in the securities and investment industry in the UK and in a growing number of major financial centres round the world. The company was founded in 1992 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Redx Oncology Ltd.
Redx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The private company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors. | Director/Board Member | - |
Former positions of Dominic Nicholas Jackson
Companies | Position | End |
---|---|---|
REDX PHARMA PLC | Director of Finance/CFO | 2019-01-30 |
Institute for Turnaround
Institute for Turnaround Miscellaneous Commercial ServicesCommercial Services Institute for Turnaround operates as a non-profit organization. It engages in professional body for all those specialized and qualified individuals working in corporate sector. The company is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
REDX PHARMA PLC | Health Technology |
Private companies | 3 |
---|---|
The Chartered Institute For Securities & Investment
The Chartered Institute For Securities & Investment General GovernmentGovernment The Chartered Institute For Securities & Investment operates as securities and investment educational institute. It is the professional body for those who work in the securities and investment industry in the UK and in a growing number of major financial centres round the world. The company was founded in 1992 and is headquartered in London, the United Kingdom. | Government |
Institute for Turnaround
Institute for Turnaround Miscellaneous Commercial ServicesCommercial Services Institute for Turnaround operates as a non-profit organization. It engages in professional body for all those specialized and qualified individuals working in corporate sector. The company is headquartered in London, the United Kingdom. | Commercial Services |
Redx Oncology Ltd.
Redx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The private company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors. | Health Technology |
- Stock Market
- Insiders
- Dominic Nicholas Jackson